IgA nephropathy (IgAN ... A recent Phase II trial revealed that felzartamab, an investigational anti-CD38 monoclonal antibody, helps to reduce proteinuria and maintain patients' kidney function.

Recent research indicates the occurrence of thromboembolic complications involving anti-phospholipid antibodies (APLA) and the anti-phospholipid syndrome (APS) in severe coronavirus disease 2019 ...

The gut microbiomes of patients with antiphospholipid syndrome show ... were persistently positive for anti-domain I (DI) antibodies. Increased Slackia and decreased Butyricimonas, a genus of ...

This paper focuses on laboratory tests necessary for a diagnosis of antiphospholipid syndrome (APS). The diagnosis starts with a selection of patients suspected of APS. Timing related to a clinical ...

In autoimmune diseases, the immune system wrongly identifies its “enemy”, and produces antibodies that attack the patient’s own cells. One of these diseases, the anti-phospholipid antibody syndrome ...

1 the definition of clinically significant antiphospholipid-antibody positivity is not well established, and thrombosis is generally multifactorial. Our objectives are to help both general ...